ENDOMETRIAL SEROUS ADENOCARCINOMA
Clinical trials for ENDOMETRIAL SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets Hard-to-Treat brain tumors in early trial
Disease control OngoingThis early-phase study tests a new drug (MLN0128) combined with bevacizumab in about 50 people with recurrent glioblastoma or other advanced solid tumors. The goal is to find the safest dose and understand side effects. The drugs work by blocking tumor growth and cutting off bloo…
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New drug cocktails show promise for Tough-to-Treat endometrial cancer
Disease control OngoingThis study tests several drug combinations in women with endometrial cancer that has returned or not responded to treatment. The drugs work by blocking cancer cell growth or helping the immune system attack tumors. The goal is to see if these combinations can slow the cancer's sp…
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New hope for advanced endometrial cancer: Three-Drug cocktails compared
Disease control OngoingThis study tested three different three-drug combinations as the first treatment for people with advanced (stage III or IV) or recurrent endometrial cancer. The goal was to see which combination worked best to stop the cancer from growing. A total of 349 participants were enrolle…
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New drug triapine tested in uterine cancer before surgery
Knowledge-focused OngoingThis early-phase trial studies how the drug triapine affects uterine serous cancer cells in 12 women scheduled for hysterectomy. Participants receive one dose of triapine before surgery, and researchers compare tumor samples taken before and after the drug to see if it slows canc…
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC